November 17, 2014 / 6:23 PM / 4 years ago

BUZZ-U.S. Stocks on the Move-Valley Financial, Baker Hughes, Celldex

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stocks dipped on Monday, following four consecutive weeks of gains on Wall Street, as energy shares fell alongside crude futures after Japan slipped into recession. The Dow Jones industrial average was up 0.20 percent at 17,669.5, the S&P 500 was up 0.12 percent at 2,042.18 and the Nasdaq Composite was down 0.28 percent at 4,675.43.

** HALLIBURTON CO, $49.87, -9.46 pct

** BAKER HUGHES INC, $66.25, +10.62 pct

Halliburton, the world’s second-largest oilfield services provider, will buy smaller rival Baker Hughes for about $35 billion in cash and stock, creating an oilfield services behemoth to take on market leader Schlumberger NV, as falling oil prices threaten to erode demand.

** ALLERGAN INC, $209.1, +5.26 pct

** ACTAVIS PLC, $247.26, +1.43 pct

Allergan agreed to be bought by Actavis for $66 billion, putting an end to a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc.

** VALLEY FINANCIAL CORP, $19.6801, +47.85 pct

** BNC BANCORP, $17.12, +1.97 pct

Lender Valley Financial will be bought by BNC Bancorp for about $101 million, or $20.50 per share, in an all-stock deal.

** CELLDEX THERAPEUTICS INC, $18.91, +33.55 pct

Interim data showed the drug maker’s brain tumor drug shrunk tumor, improved survival in patients without the disease worsening.

“Based on these data and when final medians are achieved, CLDX will look to the FDA to define a potential accelerated path to approval,” Roth Capital analysts said.

Roth raised its price target on the stock to $43 from $40, while Cowen and Co raised to $26 from $22.


The Chinese construction materials supplier forecast 2015 net income of at least $1 million, compared with its earlier expectation of breakeven. Chief Executive Xianfu Han said demand from Beijing doubled in the first quarter ended June 30.

** AMICUS THERAPEUTICS INC, $6.715, +18.01 pct

The drug developer said experimental drug migalastat showed statistically significant decrease in cardiac risks in patients with Fabry disease in a late-stage study.

** ABENGOA SA, $11.35, +24.18 pct

Close to half of Abengoa’s market value was wiped out on Friday when comments made on the company’s latest results call on the structure of its debt triggered a sell-off

** DENBURY RESOURCES INC, $9.9, -11.61 pct

Credit Suisse cut its rating and price target on the oil and natural gas company’s stock.

“We are downgrading DNR shares to ‘neutral’ from ‘outperform’ to reflect the realization that our investment thesis (mid-single-digit oil production growth and sustained dividend growth) appears no longer valid largely due to lower oil prices,” the brokerage said. It cut its price target on the stock by $3 to $16.

Denbury said on Friday it planned to cut its 2015 capital spending by 50 percent.

** EVERYWARE GLOBAL INC, $1.21, +12.04 pct

The bakerware marketer’s second-largest shareholder, Clinton Group Inc, asked greeting cards maker CSS Industries Inc to combine with EveryWare.

** DREAMWORKS ANIMATION SKG INC, $22.379, -13.99 pct

** HASBRO INC, $56.03, +3.72 pct

Negotiations between toy and board game company Hasbro and the American animation studio DreamWorks Animation have been hampered by issues regarding the structure of the combined company, according to a person familiar with the matter.

** ASCENA RETAIL GROUP INC, $12.11, -7.94 pct

Avondale Partners downgraded the apparel and footwear retailer’s stock to “market perform” from “outperform”, according to

** GERON CORP, $3.035, +9.96 pct

The drug developer’s shares continued to move after it said on Thursday it licensed its sole experimental drug to Johnson & Johnson unit for up to $935 million; including $35 million in upfront payments.

** MSB FINANCIAL CORP, $10.441, +19.46 pct

The bank holding company said it would reorganize into a stock holding company and conduct a second-step offering of new shares of common stock.

** ALCOBRA LTD, $3.48, -4.92 pct

The drug developer reported a bigger-than-expected third-quarter loss. The company said last month that a late-stage study on its experimental drug for attention-deficit hyperactivity disorder (ADHD) had failed to meet the main goal.

** SHORETEL INC, $7.255, -11.63 pct

** MITEL NETWORKS CORP, $10.22, +0.99 pct

Canadian telecom services provider Mitel said on Monday it had withdrawn its bid to buy smaller U.S. peer ShoreTel, after ShoreTel refused to engage in any talks regarding a potential transaction.


** APPROACH RESOURCES INC, $12.0021, -7.68 pct

** EXCO RESOURCES INC, $3.11, -4.01 pct

** SWIFT ENERGY CO, $6.17, -5.51 pct

Oil prices fell on Monday after a one-day rally as fourth-largest crude importer Japan fell into recession and an OPEC meeting neared without an agreement to cut production.

** LINKEDIN CORP, $221.05, -5.49 pct

The corporate networking website company’s shares were down on reports of rival professional social network from Facebook .

** HANGER INC, $19.88, -6.23 pct

The artificial limb and orthopedic brace maker postponed the release of its third-quarter results.

** CORINTHIAN COLLEGES INC, $0.1532, -4.25 pct


** CAREER EDUCATION CORP, $5.71, -3.14 pct

Shares of U.S. for-profit colleges fell in afternoon trading on Monday on that news that public and private U.S. colleges and universities will see the weakest tuition revenue growth in a decade in 2015, according to Moody’s Investors Service forecasts

** PARAGON OFFSHORE PLC, $5.09, +6.71 pct

The offshore drilling contractor said it had acquired 93.5 percent stake in Luxembourg-based jack-up drilling contractor Prospector Offshore Drilling SA.

** INOVIO PHARMACEUTICALS INC, $9.9731, -9.34 pct

The drug developer and Roche terminated a 2013 collaboration agreement to co-develop a prostate cancer drug. All of Roche’s rights to the drug, including the right to license the product to other parties, would be returned to Inovio.

** EXTERRAN HOLDINGS INC, $36.19, +7.17 pct

The natural gas-compression and oilfield equipment services provider said it plans to separate international contract operations, international aftermarket services and global fabrication businesses into a standalone company.

** TYSON FOODS INC, $42.98, +5.71 pct

The largest U.S. meat processor reported a better-than-expected quarterly profit, helped by higher prices for beef and pork.

** MGIC INVESTMENT CORP, $9.14, +2.93 pct

Susquehanna Financial Group raised its price target on the mortgage insurer’s stock by $1 to $14, the highest on Wall Street, citing potential expansion of mortgage lending and continued credit recovery of legacy portfolios in 2015.

** NOKIA OYJ, $7.67, -2.42 pct

Raymond James downgraded U.S.-listed shares of the Finnish network equipment maker to “underperform” from “market perform”. Natixis cut its rating on the Helsiniki-listed stock of the company to “reduce” from “neutral”. (Compiled by Ankit Ajmera in Bangalore; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below